Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition

Louise W. Treffers, Toine ten Broeke, Thies Rösner, J.H. Marco Jansen, Michel van Houdt, Steffen Kahle, Karin Schornagel, Paul J.J.H. Verkuijlen, Jan M. Prins, Katka Franke, Taco W. Kuijpers, Timo K. van den Berg, Thomas Valerius, Jeanette H.W. Leusen and Hanke L. Matlung
Louise W. Treffers
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toine ten Broeke
2Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thies Rösner
3Section for Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.H. Marco Jansen
2Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel van Houdt
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steffen Kahle
3Section for Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Schornagel
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J.J.H. Verkuijlen
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan M. Prins
4Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katka Franke
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taco W. Kuijpers
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
5Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timo K. van den Berg
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
6Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Valerius
3Section for Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Valerius
Jeanette H.W. Leusen
2Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanke L. Matlung
1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: h.matlung@sanquin.nl
DOI: 10.1158/2326-6066.CIR-19-0144 Published January 2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2019 to January 2021

AbstractFull-text HTMLPDF
Total3016468689

Cited By

Article Information

Volume 8, Issue 1, pp. 120-130

DOI 
https://doi.org/10.1158/2326-6066.CIR-19-0144
PubMed 
31690649

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received February 26, 2019
  • Revision received August 15, 2019
  • Accepted October 17, 2019
  • Published first November 5, 2019.

Article Versions

  • Previous version (November 5, 2019 - 05:45).
  • Previous version (December 4, 2019 - 06:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2019 American Association for Cancer Research.

Author Information

  1. Louise W. Treffers1,#,
  2. Toine ten Broeke2,#,
  3. Thies Rösner3,#,
  4. J.H. Marco Jansen2,#,
  5. Michel van Houdt1,
  6. Steffen Kahle3,
  7. Karin Schornagel1,
  8. Paul J.J.H. Verkuijlen1,
  9. Jan M. Prins4,
  10. Katka Franke1,
  11. Taco W. Kuijpers1,5,
  12. Timo K. van den Berg1,6,#,
  13. Thomas Valerius3,#,
  14. Jeanette H.W. Leusen2,#, and
  15. Hanke L. Matlung1,#,*
  1. 1Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  2. 2Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  3. 3Section for Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  4. 4Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, the Netherlands.
  5. 5Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  6. 6Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
  1. ↵*Corresponding Author:
    Hanke L. Matlung, Sanquin Research, and Landsteiner Laboratory, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands. Phone: 31-20-512-3261; Fax: 31-20-512-3310; E-mail: h.matlung{at}sanquin.nl
  1. ↵#L.W. Treffers, T. ten Broeke, T. Rösner, and J.H.M. Jansen contributed equally to this article.

  2. ↵#T.K. van den Berg, T. Valerius, J.H.W. Leusen, and H.L. Matlung contributed equally to this article.

View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 8 (1)
January 2020
Volume 8, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Louise W. Treffers, Toine ten Broeke, Thies Rösner, J.H. Marco Jansen, Michel van Houdt, Steffen Kahle, Karin Schornagel, Paul J.J.H. Verkuijlen, Jan M. Prins, Katka Franke, Taco W. Kuijpers, Timo K. van den Berg, Thomas Valerius, Jeanette H.W. Leusen and Hanke L. Matlung
Cancer Immunol Res January 1 2020 (8) (1) 120-130; DOI: 10.1158/2326-6066.CIR-19-0144

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Louise W. Treffers, Toine ten Broeke, Thies Rösner, J.H. Marco Jansen, Michel van Houdt, Steffen Kahle, Karin Schornagel, Paul J.J.H. Verkuijlen, Jan M. Prins, Katka Franke, Taco W. Kuijpers, Timo K. van den Berg, Thomas Valerius, Jeanette H.W. Leusen and Hanke L. Matlung
Cancer Immunol Res January 1 2020 (8) (1) 120-130; DOI: 10.1158/2326-6066.CIR-19-0144
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Activin A Mediates Radiation-Induced Antitumor Immunity
  • Mechanisms to CD3-Bispecific Antibody Therapy
  • Improved Estimation of T-cell Receptor Repertoire Diversity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement